Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CSTL Castle Biosciences > Detailed Quotes

CSTL Castle Biosciences

26.080
+0.660+2.60%
Close 09/30 16:00 ET
26.0800.0000.00%
Post Mkt Price 09/30 16:02 ET
High
27.295
Open
25.350
Turnover
6.25M
Low
24.690
Pre Close
25.420
Volume
236.82K
Market Cap
685.82M
P/E(TTM)
Loss
52wk High
68.650
Shares
26.30M
P/E(Static)
Loss
52wk Low
15.580
Float Cap
649.16M
Bid/Ask %
0.00%
Historical High
107.690
Shs Float
24.89M
Volume Ratio
1.60
Historical Low
15.260
Dividend TTM
--
Div Yield TTM
--
P/B
1.63
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.95%
Amplitude
10.25%
Avg Price
26.403
Lot Size
1
Float Cap
649.16M
Bid/Ask %
0.00%
Historical High
107.690
Shs Float
24.89M
Volume Ratio
1.60
Historical Low
15.260
Dividend TTM
--
P/B
1.63
Dividend LFY
--
Turnover Ratio
0.95%
Amplitude
10.25%
Avg Price
26.403
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
CEO: Mr. Derek J. Maetzold
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...